COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings or public disclosures regarding the nature and outcome of this litigation, as the current document does not provide ruling details.
Final — all horizons settled through T+60d ⚠ clustered
AZN ▼ -5.56% at T+60d
NEUTRAL call ✗ call lost -5.56% · α vs SPY -21.58% · entry $193.79 → $183.02
T+1d
+1.76%
call +1.76% · α -1.13%
$197.20
settled 6mo ago
T+5d
+3.65%
call +3.65% · α -0.65%
$200.87
settled 6mo ago
T+20d
-3.76%
call -3.76% · α -16.35%
$186.51
settled 5mo ago
T+60d
-5.56%
call -5.56% · α -21.58%
$183.02
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the District of Delaware
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Key Facts
- Case: Novartis Pharmaceuticals Corporation v. Alexion Pharmaceuticals, Inc. (1:25-cv-01269)
- Court: United States District Court for the District of Delaware
- Filed: 2026-03-30
- Parties include Novartis (NVS) and Alexion (AZN)
Financial Impact
Unknown — full opinion text not available
Risk Factors
- Potential legal exposure if the case involves material claims such as patent infringement or contract disputes
- Uncertainty due to lack of accessible ruling details
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | ct-2bt2mns6uf18-AZN |
54 reports for AZN
67% Hit rate best @ T+60▲ +13.65%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $156.97 (−3.02%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $156.97 (+4.16%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $156.97 (−1.92%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $156.97 (+3.18%) |
Showing 10 of 54
US Market Status
Market Open — Closes in 48m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access